Concepedia

Tonika Bohnert

TB

Statistics

Publications

14

Citations

524

H-Index

13

Active since

2004

Affiliations

Biogen (United States)(Current)

Sunesis (United States)

Massachusetts College of Pharmacy and Health Sciences

Development Center for Biotechnology

Massachusetts Institute of Technology

Tonika Bohnert is an author at Biogen (United States) specializing in pharmacology, pharmacy, and drug discovery.

Publications per year

2004–2021

14

Publications

14

Monoclonal antibody exposure in rat and cynomolgus monkey cerebrospinal fluid following systemic administration

Qin Wang, Luisette Delva, Paul H. Weinreb et al. · Fluids and Barriers of the CNS · 2018 · 72 citations · Full text

, , +16

Novel Bicyclic Piperazine Derivatives of Triazolotriazine and Triazolopyrimidines as Highly Potent and Selective Adenosine A<sub>2</sub><sub>A</sub>Receptor Antagonists

Hairuo Peng, G. Kumaravel, Gang Yao et al. · Journal of Medicinal Chemistry · 2004 · 61 citations · Full text

, , +10

Preclinical Pharmacokinetic/Pharmacodynamic Modeling and Simulation in the Pharmaceutical Industry: An IQ Consortium Survey Examining the Current Landscape

Edgar Schuck, Tonika Bohnert, Arijit Chakravarty et al. · The AAPS Journal · 2015 · 51 citations · Full text

, , +17

Mechanism of Drug-Drug Interactions Between Warfarin and Statins

Abdul Naveed Shaik, Tonika Bohnert, David A. Williams et al. · Journal of Pharmaceutical Sciences · 2016 · 45 citations

, , +12

Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis

Brian T. Hopkins, Eris Bame, Bekim Bajrami et al. · Journal of Medicinal Chemistry · 2021 · 42 citations · Full text

, , +14

1–5 of 14